1-17 of 17
Nathan Denlinger
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Initial Results of a First-in-Human, Phase I Study Point-of-Care Manufacturing of Trispecific CAR-T Cells Targeting CD19/20/22 in B-Cell Malignancies

Sumithira Vasu, Evandro Bezerra, Nathan Denlinger, Nicole Szuminski, Dina Schneider, Pradyot Dash, Louisa Wirthlin, Narendranath Epperla, Yazeed Sawalha, Jennifer A. Woyach, Kerry A. Rogers, Seema A Bhat, Gregory K Behbehani, Karilyn T. Larkin, Adam S Kittai, Wing Chan, Ashley Angell Krull, Shamama Nishat, Lynn O'Donnell, Lapo Alinari, Marcos de Lima
Journal: Blood
Blood (2024) 144 (Supplement 1): 2078.
https://doi.org/10.1182/blood-2024-207532
Published: 2024
Journal Articles

Interim Results from a Phase 2 Pivotal Study (DALY II USA) of Tandem CD20-CD19-Directed Non-Cryopreserved CAR-T Cells - Zamtocabtagene Autoleucel (Zamto-Cel) in Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma

Nirav N. Shah, Richard T. Maziarz, Caron A. Jacobson, Patrick B. Johnston, Sunil Abhyankar, Iris Isufi, Miguel Angel Perales, Monalisa Ghosh, Matthew Ulrickson, Allison C. Rosenthal, Javier L. Munoz, Nancy M. Hardy, Aaron P. Rapoport, Reem Karmali, Farrukh T. Awan, Matthew Stuart McKinney, Mitchell Horwitz, Matthew Lunning, Nathan Denlinger, Marek Ancukiewicz, Madhavi Nallewar, Kimberly C Coleman, Esther Eromosele, Remigiusz Kaleta, Johanna Theruvath, Anna Wijatyk, David B. Miklos
Journal: Blood
Blood (2024) 144 (Supplement 1): 68.
https://doi.org/10.1182/blood-2024-208539
Published: 2024
Journal Articles

Association between Post-CART Terminal Complement Complex Levels and Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS)

Evandro Bezerra, George Durisek, III, Qiuhong Zhao, Nathan Denlinger, Timothy Voorhees, Gabriela Sanchez-Petitto, Francesca Cottini, Audrey M. Sigmund, Yazeed Sawalha, Polina Shindiapina, Sarah A. Wall, David A. Bond, Hannah Choe, Jonathan E. Brammer, Beth Christian, Sam Penza, Samantha M. Jaglowski, Kami J. Maddocks, Spero Cataland, Marcos de Lima, Sumithira Vasu
Journal: Blood
Blood (2024) 144 (Supplement 1): 3446.
https://doi.org/10.1182/blood-2024-198872
Published: 2024
Journal Articles

Comparison of Two Myeloablative Total-Body Irradiation (MAC-TBI) Regimens: 1200 Cgy Vs 800 Cgy of TBI for Allogeneic Stem Cell Transplantation in Adults with Hematological Malignancies

Gabriela Sanchez-Petitto, Ying Huang, Evandro Bezerra, Jonathan E. Brammer, Hannah Choe, Nathan Denlinger, Polina Shindiapina, Sam Penza, Sarah A Wall, Gregory K Behbehani, James S. Blachly, Bradley Wayne Blaser, Uma Borate, Ann-Kathrin Eisfeld, Nicole R. Grieselhuber, Kristin L Koenig, Karilyn T. Larkin, Meixiao Long, Alice Mims, Andrew Srisuwananukorn, Ayman Saad, Sumithira Vasu, Marcos de Lima
Journal: Blood
Blood (2024) 144 (Supplement 1): 7303.
https://doi.org/10.1182/blood-2024-194146
Published: 2024
Journal Articles

GATA2 -Mutated AML: Clinical Outcomes and Spectrum of Infections in Patients Undergoing or Not Allogeneic Stem Cell Transplantation

Gabriela Sanchez-Petitto, Zeinab El Boghdadly, Deedra Nicolet, Julia Cooper, Ann-Kathrin Eisfeld, Victoria Klein, Michael C Walker, Krzysztof Mrózek, Evandro Bezerra, Jonathan E. Brammer, Nathan Denlinger, Polina Shindiapina, Sam Penza, Sarah A. Wall, Gregory K Behbehani, James S. Blachly, Bradley Wayne Blaser, Uma Borate, Nicole R. Grieselhuber, Kristin L Koenig, Karilyn T. Larkin, Meixiao Long, Alice Mims, Andrew Srisuwananukorn, Sumithira Vasu, Marcos de Lima
Journal: Blood
Blood (2024) 144 (Supplement 1): 7309.
https://doi.org/10.1182/blood-2024-202650
Published: 2024
Journal Articles

Spatial Tissue Analysis of Secondary Sarcoma Following CAR T Cell Therapy for B Cell Lymphoma

Dina Schneider, Jia-Jye Lee, Jinling Wang, Robert Pinard, Peirong Hu, Kun Luo, Ngoc Tran, Yazeed Sawalha, Nathan Denlinger, Evandro Bezerra, Pradyot Dash, Ashley Angell Krull, Lynn O'Donnell, Lapo Alinari, Dan Jones, Marcos de Lima, Sumithira Vasu
Journal: Blood
Blood (2024) 144 (Supplement 1): 7139.
https://doi.org/10.1182/blood-2024-203633
Published: 2024
Journal Articles

Acute Kidney Injury Following Chimeric Antigen Receptor T-Cell Therapy Is Associated with Inferior Survival for Patients with Relapsed or Refractory Large B-Cell Lymphoma

John Sharp, Qiuhong Zhao, Timothy Voorhees, David A. Bond, Yazeed Sawalha, John C. Reneau, Audrey M. Sigmund, Walter Hanel, Lalit Sehgal, Lapo Alinari, Robert Baiocchi, Jonathan E. Brammer, Kami J. Maddocks, Beth Christian, Evandro Bezerra, Nathan Denlinger, Sumithira Vasu, Marcos de Lima, Jason Prosek, Narendranath Epperla
Journal: Blood
Blood (2024) 144 (Supplement 1): 3747.
https://doi.org/10.1182/blood-2024-203798
Published: 2024
Journal Articles

Steroid Prophylaxis in Patients Receiving CAR T-Cell Therapy for Relapsed and Refractory Non-Hodgkin Lymphoma

Jacob Butman, Alma Habib, Rina Li Welkie, Yazeed Sawalha, Audrey M. Sigmund, Beth Christian, Kami J. Maddocks, Walter Hanel, David A. Bond, Lapo Alinari, Robert Baiocchi, Hannah Choe, John C. Reneau, Gabriela Sanchez-Petitto, Jonathan E. Brammer, Evandro Bezerra, Timothy Voorhees, Sumithira Vasu, Sarah A. Wall, Marcos de Lima, Nathan Denlinger
Journal: Blood
Blood (2024) 144 (Supplement 1): 4507.
https://doi.org/10.1182/blood-2024-206559
Published: 2024
Journal Articles

Efficacy of Siltuximab for Chimeric Antigen Receptor T-Cell Therapy Toxicities - a Multicenter Retrospective Analysis

Amneet K Bajwa, Qiuhong Zhao, Marcus Johannes Geer, Agrima Mian, Chenyu Lin, David Frame, James Westholder, Justin Tossey, Monalisa Ghosh, Ahmed Galal, Nausheen Ahmed, Joseph E. Maakaron, Nathan Denlinger, Marcos de Lima, Narendranath Epperla, Paolo F. Caimi, Timothy Voorhees
Journal: Blood
Blood (2023) 142 (Supplement 1): 4502.
https://doi.org/10.1182/blood-2023-179620
Published: 2023
Journal Articles

A Phase I Clinical Trial of Point-of-Care Manufactured Fresh Anti-CD19/20/22 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Lymphoid Malignancies (Non-Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia, B Prolymphocytic Leukemia)

Sumithira Vasu, Lapo Alinari, Nicole Szuminski, Dina Schneider, Nathan Denlinger, Wing Keung Chan, Khalid Parris, Nidhi Sharma, Hillary Bradbury, Beth Daneault, Lynn O'Donnell, Boro Dropulic, Marcos J.G. de Lima
Journal: Blood
Blood (2022) 140 (Supplement 1): 7474–7475.
https://doi.org/10.1182/blood-2022-167340
Published: 2022
Journal Articles

Impact of diagnostic genetics on remission MRD and transplantation outcomes in older patients with AML

CME Clinical Trials & Observations
H. Moses Murdock, Haesook T. Kim, Nathan Denlinger, Pankit Vachhani, Bryan Hambley, Bryan S. Manning, Shannon Gier, Christina Cho, Harrison K. Tsai, Shannon McCurdy, Vincent T. Ho, John Koreth, Robert J. Soiffer, Jerome Ritz, Martin P. Carroll, Sumithira Vasu, Miguel-Angel Perales, Eunice S. Wang, Lukasz P. Gondek, Steven Devine, Edwin P. Alyea, III, R. Coleman Lindsley, Christopher J. Gibson
Journal: Blood
Blood (2022) 139 (24): 3546–3557.
https://doi.org/10.1182/blood.2021014520
Published: 2022
Includes: Supplemental data
Journal Articles

Outcomes of Large B-Cell Lymphoma Patients By Post CAR-T Salvage Regimen at a Single Institution

Audrey M. Sigmund, Nathan Denlinger, Amneet Bajwa, Patrick Elder, David A. Bond, Jonathan E Brammer, Ayman Saad, Sam Penza, Marcos J.G. de Lima, Samantha Jaglowski, Adam S Kittai
Journal: Blood
Blood (2021) 138 (Supplement 1): 3851.
https://doi.org/10.1182/blood-2021-148751
Published: 2021
Journal Articles

Cardiac Arrhythmias and Mortality after Hematopoietic Stem Cell Transplant (HSCT): A Systematic Review and Meta-Analysis

Saad Ullah Malik, Zachary Braunstein, Sumithira Vasu, Sam Penza, Ayman Saad, Nathan Denlinger, Marcos J.G. de Lima, Ajay Vallakati, Ragavendra Baliga, Samantha Jaglowski, Jonathan E. Brammer, Daniel Addison
Journal: Blood
Blood (2021) 138 (Supplement 1): 2918.
https://doi.org/10.1182/blood-2021-152223
Published: 2021
Journal Articles

Genetic Alterations at Diagnosis Predict Outcome of AML Patients Age 60 or Older Undergoing Allogeneic Transplantation in First Remission

H. Moses Murdock, BS, Haesook T. Kim, PhD, Bryan Hambley, MD, Pankit Vachhani, MD, Nathan Denlinger, MS, DO, Shannon H. Gier, BS, Christina Cho, MD, Miguel-Angel Perales, MD, John Koreth, MBBS, DPhil, Vincent T. Ho, Robert J. Soiffer, MD, Shannon R. McCurdy, MD, Martin Carroll, MD, Sumithira Vasu, MDMBBS, Eunice S. Wang, MD, Lukasz P. Gondek, MDPhD, Steven Devine, MD, Edwin P. Alyea, III, MD, Christopher J. Gibson, MD, R. Coleman Lindsley, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 48.
https://doi.org/10.1182/blood-2019-125967
Published: 2019
Journal Articles

Characteristics, Treatment Patterns, and Outcomes in Primary Cutaneous Gamma Delta T Cell Lymphoma (PCGDTCL): A Real World Multi-Institutional Analysis of a Rare Malignancy

Kevin A. David, MD, Melissa Pulitzer, MD, Joan Guitart, MD, Maria Estela Martinez-Escala, MD, Shamir Geller, MD, Yaqun Wang, N. Nora Bennani, MD, Kay M. Ristow, BS, Daniel J. Landsburg, MD, Nicole Winchell, Paul Haun, MD, Pamela Allen, MDMSc, Basem M. William, MRCP,MD, Nathan Denlinger, MS, DO, Neha Mehta-Shah, MD, Ryan A. Wilcox, MD PhD, Alexandra Hristov, Tatyana A. Feldman, MD, Alex Weller, Andrew M. Evens, DO, MSc, Steven M. Horwitz, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4028.
https://doi.org/10.1182/blood-2019-130223
Published: 2019
Journal Articles

Enhanced Spontaneous Anti-Tumor Cytotoxicity of Natural Killer Cells in Cutaneous T-Cell Lymphoma Patients

Bethany L Mundy-Bosse, PhD, Nathan Denlinger, MS, DO, Susan Huang, MD, Li Chen, Hsiaoyin Mao, David Kline, Eric McLaughlin, Youssef Youssef, Karen Young, Gerard Lozanski, MD, Aharon G. Freud, MD PhD, Pierluigi Porcu, MD, Basem M. William, MD, Michael A. Caligiuri, MD, Anjali Mishra, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2753.
https://doi.org/10.1182/blood.V130.Suppl_1.2753.2753
Published: 2017
Journal Articles

Performance of Quick Sepsis-Related Organ Failure Assessment (qSOFA) in Predicting Adverse Outcomes in Acute Leukemia Patients Receiving Induction Chemotherapy

John Vaughn, MD, David Kline, PhD, Nathan Denlinger, DO, Leslie Andritsos, MD, Alison R. Walker, MD MPH
Journal: Blood
Blood (2016) 128 (22): 2413.
https://doi.org/10.1182/blood.V128.22.2413.2413
Published: 2016